Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.
about
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and diseasePolyunsaturated fatty acid metabolism in prostate cancerO-GlcNAcylation and the Metabolic Shift in High-Proliferating Cells: All the Evidence Suggests that Sugars Dictate the Flux of Lipid Biogenesis in Tumor ProcessesInnovation in metabolomics to improve personalized healthcareLipid metabolism in prostate cancerDual fatty acid synthase and HER2 signaling blockade shows marked antitumor activity against breast cancer models resistant to anti-HER2 drugsFatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcomeFatty Acids in Membranes as Homeostatic, Metabolic and Nutritional Biomarkers: Recent Advancements in Analytics and DiagnosticsCrystal structure of the human fatty acid synthase enoyl-acyl carrier protein-reductase domain complexed with triclosan reveals allosteric protein-protein interface inhibitionEfficacy of a non-hypercalcemic vitamin-D2 derived anti-cancer agent (MT19c) and inhibition of fatty acid synthesis in an ovarian cancer xenograft modelBlockade of fatty acid synthase triggers significant apoptosis in mantle cell lymphomaProteomic Upregulation of Fatty Acid Synthase and Fatty Acid Binding Protein 5 and Identification of Cancer- and Race-Specific Pathway Associations in Human Prostate Cancer Tissues.p63 promotes cell survival through fatty acid synthaseSerum low-density lipoprotein and low-density lipoprotein expression level at diagnosis are favorable prognostic factors in patients with small-cell lung cancer (SCLC).Inhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myo-inositol in A/J miceCancer cell-associated fatty acid synthase activates endothelial cells and promotes angiogenesis in colorectal cancer.Blocking fatty acid synthase inhibits tumor progression of human osteosarcoma by regulating the human epidermal growth factor receptor 2/phosphoinositide 3-kinase/protein kinase B signaling pathway in xenograft modelsEstablishment and genomic characterization of mouse xenografts of human primary prostate tumors.The Toxic Effects of Tetrachlorobisphenol A in Saccharomyces cerevisiae Cells via Metabolic Interference.Alpha-mangostin inhibits intracellular fatty acid synthase and induces apoptosis in breast cancer cells.Metabolic genes in cancer: their roles in tumor progression and clinical implicationsCholesterol sulfate imaging in human prostate cancer tissue by desorption electrospray ionization mass spectrometryOxidized LDL receptor 1 (OLR1) as a possible link between obesity, dyslipidemia and cancer.Novel nuclear localization of fatty acid synthase correlates with prostate cancer aggressivenessA low carbohydrate, high protein diet combined with celecoxib markedly reduces metastasis.Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker.Up-regulated FASN expression promotes transcoelomic metastasis of ovarian cancer cell through epithelial-mesenchymal transitionFatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival.Association of lipid metabolism with ovarian cancerShedding new light on lipid biology with coherent anti-Stokes Raman scattering microscopyEGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy.Profiling of serum metabolites in canine lymphoma using gas chromatography mass spectrometryMetabolic imbalance and prostate cancer progression.Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stressProteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancerHigh-calorie diet exacerbates prostate neoplasia in mice with haploinsufficiency of Pten tumor suppressor geneLipid Signaling in Tumorigenesis.Alpha-2-glycoprotein 1(AZGP1) regulates biological behaviors of LoVo cells by down-regulating mTOR signaling pathway and endogenous fatty acid synthesis.New strategies in prostate cancer: targeting lipogenic pathways and the energy sensor AMPKGenetic variants in de novo lipogenic pathway genes predict the prognosis of surgically-treated hepatocellular carcinoma.
P2860
Q24289344-9E89EF38-9D23-4424-8636-DF0B82A0F6F6Q24629893-61480DBF-19FC-4B6E-8C8B-7944F8D9613BQ26770270-260E2731-C6E4-4871-A798-FDBA9C1D4B57Q26830021-A6C2244C-4626-406F-874B-707E3D1E8AF3Q27025766-06B287DA-A17F-4305-BA0F-1BE1E6F0D9D6Q27303674-18C3FF68-A320-4A85-9F36-4C60FC61F363Q27318509-357371E2-B0EF-44D3-A0AB-1DD32FB5817AQ28072597-9DE8F4F2-9243-4976-AD65-3E946BE608ECQ28383149-284516B7-84BD-42A0-BD11-4D950DAC307FQ28482093-C49414B7-3E45-41D2-AE9A-576B88A0E221Q28730808-F62959C9-2949-40E1-BD96-C322991603F3Q30357469-B7B7B07A-7435-490B-AA90-6CA570346592Q33466069-11EC4D5E-4B6A-41CF-B640-3DC2CFA3DABEQ33564335-96A49B76-0710-4CE2-A4F1-55E7E6C3F37DQ33615285-7E74B860-286D-4A21-982B-2021EC4510C5Q33705257-57F7AF11-49EE-4D99-A2FD-525897F1078AQ33723733-259A227E-3480-4407-B139-53BEE889E71BQ33745240-AC5CE4C6-6B45-40CC-99D3-0FC0BBB38F9FQ33752761-1BE43499-50C3-43A0-90E3-876BE95171FBQ33765134-A6B0A55F-11AD-460C-96DB-F55F9E6E2501Q33772469-E4C6206D-3322-42A7-8D06-8072C5E601EAQ33858266-919E63C0-0171-4FEC-8082-38337E121871Q33921431-9472B540-91B3-4E65-ADC2-E320787A6CB0Q33978062-1E25D16E-BFB4-4832-9F58-082A21CAA6D2Q34041458-DA22B334-C968-42C4-9DB3-12660E204F51Q34058540-E87C9856-E31E-4277-9A49-9CEBD4CC8E35Q34072226-B4CA58C5-42E6-4D8F-BD15-EC2378C4D2E2Q34131778-DDEA8494-0414-463F-8016-02865A36587CQ34171997-F705B3F9-43D1-488D-847A-53A82F1F5821Q34187941-5101B7FB-B3EE-4E19-9130-4B16D1C87E21Q34296575-7D77B3B2-3C43-490D-85FE-2FBB9C534F55Q34749776-66B6589A-CD26-4696-8848-22A71D810A90Q34794028-87F0FCEA-F25B-40DB-9AFA-5D7777D2F6E9Q34978574-EB1C2706-99B7-4B28-B8F9-A25A84D777CBQ35082335-BF4F9545-EBA6-4E75-98A8-2184BF4662D4Q35113473-2035C288-8128-427B-A64D-BF0DF79FB714Q35136532-0E8EFA5D-7570-48F1-A10A-81A5D4A7AC5EQ35185381-6783A060-B7CF-4298-8E81-F2F8D4685EE6Q35222084-4440676A-4465-4A82-8817-69803228748FQ35233688-DE5625B6-658C-40C8-9C38-AFC7C7E2DD10
P2860
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.
@ast
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.
@en
type
label
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.
@ast
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.
@en
prefLabel
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.
@ast
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.
@en
P2093
P2860
P50
P356
P1476
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.
@en
P2093
Alessandro Fornari
Aravind Subramanian
Carmen Priolo
Chiara Grisanzio
Christopher Fiore
Emanuele Palescandolo
Eyoung Shin
Fumika Inazuka
Giorgia Zadra
P2860
P304
P356
10.1093/JNCI/DJP030
P407
P577
2009-03-24T00:00:00Z